MIT research offers new hope for Alzheimer's patients

April 27, 2006

MIT brain researchers have developed a "cocktail" of dietary supplements, now in human clinical trials, that holds promise for the treatment of Alzheimer's disease

For years, doctors have encouraged people to consume foods such as fish that are rich in omega-3 fatty acids because they appear to improve memory and other brain functions.

The MIT research suggests that a cocktail treatment of omega-3 fatty acids and two other compounds normally present in the blood, could delay the cognitive decline seen in Alzheimer's disease, which afflicts an estimated 4 million to 5 million Americans.

"It's been enormously frustrating to have so little to offer people that have (Alzheimer's) disease," said Richard Wurtman, the Cecil H. Green Distinguished Professor of Neuropharmacology at MIT, who led the research team. The study appears in the May 9 issue of Brain Research.

Wurtman will present the research at the International Academy of Nutrition and Aging 2006 Symposium on Nutrition and Alzheimer's Disease/Cognitive Decline in Chicago on Tuesday, May 2.

The three compounds in the treatment cocktail -- omega-3 fatty acids, uridine and choline -- are all needed by brain neurons to make phospholipids, the primary component of cell membranes.

After adding those supplements to the diets of gerbils, the researchers observed a dramatic increase in the amount of membranes that form brain cell synapses, where messages between cells are relayed. Damage in brain synapses is believed to cause the dementia that characterizes Alzheimer's disease.

If the successful results obtained in gerbils can be duplicated in the ongoing human trials, the new treatment could offer perhaps not a cure but a long-term Alzheimer's treatment similar to what L-dopa, a dopamine precursor, does for Parkinson's patients, said Wurtman, a professor in the Department of Brain and Cognitive Sciences.

"It doesn't cure Parkinson's, but what it does do is to help replace something that's missing. It's not permanent, but it has had an enormous impact on people who have Parkinson's," he said.

The new potential treatment offers a different approach from the traditional tactic of targeting the amyloid plaques and tangles that develop in the brains of Alzheimer's patients. Until recently, most researchers believed these plaques and tangles caused the cognitive decline. But the failure of this hypothesis to lead to an effective treatment for Alzheimer's disease has caused some scientists to theorize that, though the plaques and tangles are always associated with the disease, they may not be the main cause of the dementia, nor the best target for treating it.

Instead, the new research focuses on brain synapses, where neurotransmitters such as dopamine, acetylcholine, serotonin and glutamate carry messages from presynaptic neurons to receptors in the membranes of postsynaptic neurons. In Alzheimer's patients, synapses in the cortex and hippocampus, which are involved in learning and memory, are damaged.

After the dietary supplements were given, the researchers detected a large increase in the levels of specific brain proteins known to be concentrated within synapses, indicating that more synaptic membranes had formed, Wurtman said. Synaptic membrane protein levels rose if the gerbils were given either omega-3 fatty acids or uridine plus choline. However, the most dramatic upsurge was observed in gerbils fed all three compounds.

"To my knowledge, this is the first concrete explanation for the behavioral effects of taking omega-3 fatty acids," said Wurtman.

Choline can be found in meats, nuts and eggs, and omega-3 fatty acids are found in a variety of sources, including fish, eggs, flaxseed and meat from grass-fed animals. Uridine, which is found in RNA and produced by the liver and kidney, is not obtained from the diet. However, uridine is found in human breast milk, which is a good indication that supplementary uridine is safe for humans to consume, Wurtman said.

Recent studies by the researchers at MIT, and by scientists at Cambridge University in England, showed that either uridine or omega-3 fatty acids can promote the growth of neurites, which are small outgrowths of neuronal cell membranes. That further supports the hypothesis that omega-3 fatty acids increase synaptic membrane formation, said Wurtman.

Alzheimer's patients in the clinical trials, which will involve multiple medical centers, are being given a drink that contains the compounds under study, or a taste-matched placebo.

"If it works as well on the brains of people with Alzheimer's disease as it does in laboratory animals, I think there will be a lot of interest," Wurtman said.

Other authors on the paper are Ismail Ulus, Mehmet Cansev, Carol Watkins, Lei Wang and George Marzloff of MIT's Department of Brain and Cognitive Sciences. Ulus and Cansev also work at the Uludag University School of Medicine in Turkey.

Source: MIT

Explore further: Schizophrenia disrupts the brain's entire communication system, researchers say

Related Stories

Schizophrenia disrupts the brain's entire communication system, researchers say

October 17, 2017
Some 40 years since CT scans first revealed abnormalities in the brains of schizophrenia patients, international scientists say the disorder is a systemic disruption to the brain's entire communication system.

New class of molecules may protect brain from stroke, neurodegenerative diseases

September 28, 2017
Research led by Nicolas Bazan, MD, PhD, Boyd Professor and Director of the Neuroscience Center of Excellence at LSU Health New Orleans, has discovered a new class of molecules in the brain that synchronize cell-to-cell communication ...

Is it Alzheimer's or another dementia form? Why doctors need to distinguish

July 28, 2017
Alzheimer's disease now affects an estimated 5.5 million Americans, and after decades of feverish work, researchers have so far failed to find a treatment that halts or reverses the inexorable loss of memory, function and ...

Seven steps to keep your brain healthy from childhood to old age

September 7, 2017
A healthy lifestyle benefits your brain as much as the rest of your body—and may lessen the risk of cognitive decline (a loss of the ability to think well) as you age, according to a new advisory from the American Heart ...

Brain fatty acid levels dysregulated in Alzheimer's disease

March 21, 2017
The concentration of six unsaturated fatty acids in key brain regions are associated with Alzheimer disease (AD) cognitive symptoms and neuropathology, according to a study publishing in PLOS Medicine.

Omega-3 dietary supplements pass the blood-brain barrier

December 4, 2013
(Medical Xpress)—New research from Karolinska Institutet shows that omega-3 fatty acids in dietary supplements can cross the blood brain barrier in people with Alzheimer's disease, affecting known markers for both the disease ...

Recommended for you

Neuroscientists build case for new theory of memory formation

October 23, 2017
Learning and memory are generally thought to be composed of three major steps: encoding events into the brain network, storing the encoded information, and later retrieving it for recall.

Activation of immune T cells leads to behavioral changes

October 23, 2017
Scientists from the RIKEN Center for Integrative Medical Sciences in Japan and collaborators have found that T cells—immune cells that help to protect the body from infections and cancer—change the body's metabolism when ...

Novel technique explains herbicide's link to Parkinson's disease

October 23, 2017
Northwestern Medicine scientists have used an innovative gene editing technique to identify the genes that may lead to Parkinson's disease after exposure to paraquat, a commonly-used herbicide.

Major study of genetics of breast cancer provides clues to mechanisms behind the disease

October 23, 2017
Seventy-two new genetic variants that contribute to the risk of developing breast cancer have been identified by a major international collaboration involving hundreds of researchers worldwide.

Exploring disease predisposition to deliver personalized medicine

October 23, 2017
Geneticists from the University of Geneva have taken an important step towards true predictive medicine. Exploring the links between diseases and tissue-specific gene activity, they have been able to build a model that constitutes ...

Running on autopilot: Scientists find important new role for 'daydreaming' network

October 23, 2017
A brain network previously associated with daydreaming has been found to play an important role in allowing us to perform tasks on autopilot. Scientists at the University of Cambridge showed that far from being just 'background ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.